Skip to Content

R 534 (Divalproex Sodium Extended-Release 500 mg)

Pill with imprint R 534 is Gray, Elliptical / Oval and has been identified as Divalproex Sodium Extended-Release 500 mg. It is supplied by Dr. Reddy's Laboratories Ltd..

Divalproex sodium is used in the treatment of bipolar disorder; epilepsy; mania; migraine prevention; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for R 534

Divalproex sodium extended-release 500 mg R 534 Front
Divalproex sodium extended-release 500 mg R 534 Back
Divalproex sodium extended-release 500 mg R 534
Divalproex sodium extended-release 500 mg R 534

Divalproex Sodium Extended-Release

Imprint:
R 534
Strength:
500 mg
Color:
Gray
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy's Laboratories Ltd.
National Drug Code (NDC):
55111-0534

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide